Sector revisions Genmab A/S

Equities

GMAB

DK0010272202

Biotechnology & Medical Research

Market Closed - Nasdaq Copenhagen Other stock markets 16:20:00 05/12/2025 GMT			5-day change	1st Jan Change
2,032.00 ^DKK	-1.45%		-0.34%	+36.15%

12-04	Genmab A/S Presents at Citi Annual Global Healthcare Conference 2025, Dec-04-2025 09:45 AM
12-04	Genmab Closes $2.5 Billion Senior Notes Offering	MT

Sector:

Location:

X axis:

Main competitors

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	GENMAB A/S							14
	ARGENX SE							13
	INSMED INCORPORATED							18
	WUXI APPTEC CO., LTD.							19
	BIONTECH SE							19
	WUXI BIOLOGICS (CAYMAN) INC.							25
	AKESO, INC.							21
	SUMMIT THERAPEUTICS INC.							13
	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.							17
	MADRIGAL PHARMACEUTICALS, INC.							15
	EXELIXIS, INC.							18
	ARROWHEAD PHARMACEUTICALS, INC.							12
	NUVALENT, INC.							17
	CYTOKINETICS, INCORPORATED							18
	ABL BIO INC.							6
	MERUS N.V.							13
	Average							16
	Weighted average by Cap.							17

Bio Therapeutic Drugs

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

Unlock them now!